OTCM
PTAXY
Market cap2.57bUSD
, Last price
USD
Name
PALTAC Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. Paltac Corporation was incorporated in 1928 and is headquartered in Osaka, Japan. Paltac Corporation operates as a subsidiary of MediPal Holdings Corporation.
Key people
Yukinori Sakakibara
Executive Officer, Vice President of Chubu Office · since 2025
Naoki Sawada
Executive Officer, President of Hokkaido Office · since 2020
Yoshi Shirota
Executive Officer, Chief Director of Overseas Business · since 2025
Hirokazu Takayama
Executive Officer, President of Chubu Office · since 2023
Koji Yoshida
Executive Officer, Deputy Chief Director of Overseas Business · since 2019
Hiroshi Yoshihara
Executive Officer, President of Chugoku and Shikoku Office · since 2023
Director · since 2023
Masaharu Shimada
Senior Managing Executive Officer, Chief Director of Business Planning, Director · since 2023
Yoshitaka Yamada
Senior Managing Executive Officer, Chief Senior Chief Director of Sales, Director · since 2025
President, Representative Director · since 2023
Akihito Hattori
Independent Director · since 2023
Independent Director · since 2025
Shingo Inui
Independent Director · since 2022
Kaori Oishi
Independent Director · since 2017
Mineko Orisaku
Independent Director · since 2021
Tatsuomi Takamori
Independent Director · since 2022
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||